{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:49:27Z","timestamp":1785898167397,"version":"3.56.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["P20GM113226"],"award-info":[{"award-number":["P20GM113226"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AA026980"],"award-info":[{"award-number":["U01AA026980"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AA026934"],"award-info":[{"award-number":["U01AA026934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AA026926"],"award-info":[{"award-number":["U01AA026926"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00AA030627"],"award-info":[{"award-number":["R00AA030627"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2I01CX002219-05A2"],"award-info":[{"award-number":["2I01CX002219-05A2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["P50AA024337"],"award-info":[{"award-number":["P50AA024337"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01CX002219-05A2"],"award-info":[{"award-number":["2I01CX002219-05A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cld.2024.06.018","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T07:21:44Z","timestamp":1723533704000},"page":"731-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Josiah E.","family":"Hardesty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2024.06.018_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.acc.2023.02.001","article-title":"Drinking and laboratory biomarkers, and nutritional status characterize the clinical presentation of early-stage alcohol-associated liver disease","volume":"114","author":"Vatsalya","year":"2023","journal-title":"Adv Clin Chem"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib2","doi-asserted-by":"crossref","first-page":"e16170","DOI":"10.1016\/j.heliyon.2023.e16170","article-title":"Dietary fiber intake and mortality among survivors of liver cirrhosis: a prospective cohort study","volume":"9","author":"Hariri","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7861\/clinmedicine.10-6-624","article-title":"Malnutrition: causes and consequences","volume":"10","author":"Saunders","year":"2010","journal-title":"Clin Med"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cld.2011.12.009","article-title":"Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses","volume":"16","author":"Periyalwar","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cld.2021.03.002","article-title":"Malnutrition and alcohol-associated hepatitis","volume":"25","author":"McClain","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans administration cooperative study group on alcoholic hepatitis","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","article-title":"Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies","volume":"19","author":"Mendenhall","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/jhep.2000.20524","article-title":"Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites","volume":"32","author":"Pirlich","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib10","first-page":"509","article-title":"Handgrip dynamometry: a surrogate marker of malnutrition to predict the prognosis in alcoholic liver disease","volume":"29","author":"Gaikwad","year":"2016","journal-title":"Ann Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2024.06.018_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.1948.02900080001001","article-title":"Dietary treatment of cirrhosis of the liver; results in 124 patients observed during a 10 year period","volume":"138","author":"Patek","year":"1948","journal-title":"J\u00a0Am Med Assoc"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0148607193017002119","article-title":"Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis","volume":"17","author":"Hirsch","year":"1993","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"5","key":"10.1016\/j.cld.2024.06.018_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/07315724.1999.10718881","article-title":"Nutritional support in alcoholic cirrhotic patients improves host defenses","volume":"18","author":"Hirsch","year":"1999","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"6709","key":"10.1016\/j.cld.2024.06.018_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.299.6709.1202","article-title":"Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver","volume":"299","author":"Swart","year":"1989","journal-title":"BMJ"},{"issue":"11\u201312","key":"10.1016\/j.cld.2024.06.018_bib15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.nut.2013.05.016","article-title":"Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis","volume":"29","author":"Iwasa","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.cld.2024.06.018_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jnutbio.2018.05.003","article-title":"Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients","volume":"59","author":"Vatsalya","year":"2018","journal-title":"J\u00a0Nutr Biochem"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0115426506021003255","article-title":"The use of selected nutrition supplements and complementary and alternative medicine in liver disease","volume":"21","author":"Hanje","year":"2006","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.cld.2024.06.018_bib18","series-title":"Nutrition, diet therapy, and the liver","first-page":"1","article-title":"Longterm management of alcoholic liver disease","author":"Zhou","year":"2010"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11938-017-0132-4","article-title":"Role of zinc in the development\/progression of alcoholic liver disease","volume":"15","author":"McClain","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/07315724.2000.10718908","article-title":"Preliminary observation: oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients","volume":"19","author":"Kugelmas","year":"2000","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(92)91801-A","article-title":"Accelerated improvement of alcoholic liver disease with enteral nutrition","volume":"102","author":"Kearns","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN guidelines on enteral nutrition: liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607115621863","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.)","volume":"40","author":"McClave","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cld.2024.06.018_bib27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/01.ALC.0000093744.12232.34","article-title":"I.\u00a0Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse\/physician teams","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"10.1016\/j.cld.2024.06.018_bib28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1478-3231.2006.01419.x","article-title":"The effects of pentoxifylline on liver regeneration after portal vein ligation in rats","volume":"27","author":"Kucuktulu","year":"2007","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.50.2.241","article-title":"Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis","volume":"50","author":"Raetsch","year":"2002","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib32","doi-asserted-by":"crossref","first-page":"G681","DOI":"10.1152\/ajpgi.00098.2006","article-title":"Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease","volume":"291","author":"Gobejishvili","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.cld.2024.06.018_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1067\/mai.2001.119555","article-title":"Cyclic nucleotide phosphodiesterases","volume":"108","author":"Essayan","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.cld.2024.06.018_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00011-005-1386-1","article-title":"The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide","volume":"54","author":"Kwak","year":"2005","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pupt.2004.09.031","article-title":"The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients","volume":"18","author":"Ouagued","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2024.06.018_bib36","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.1840220516","article-title":"Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis","volume":"22","author":"Le Moine","year":"1995","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2024.06.018_bib37","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H","article-title":"Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells","volume":"29","author":"Platzer","year":"1999","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","article-title":"Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production","volume":"63","author":"Eigler","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0022-3565(25)24562-1","article-title":"Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors","volume":"272","author":"Verghese","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.cld.2024.06.018_bib40","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.155.10.4909","article-title":"Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages","volume":"155","author":"Kambayashi","year":"1995","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib41","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.06.018_bib42","first-page":"20","article-title":"Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial","volume":"60","author":"Sidhu","year":"2012","journal-title":"J\u00a0Assoc Physicians India"},{"issue":"13","key":"10.1016\/j.cld.2024.06.018_bib43","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2024.06.018_bib44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A\u00a0randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11901-012-0158-y","article-title":"Alcoholic hepatitis: steroids vs. Pentoxifylline","volume":"12","author":"Smart","year":"2013","journal-title":"Curr Hepat Rep"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2008-0283","article-title":"Minireview: latest perspectives on antiinflammatory actions of glucocorticoids","volume":"23","author":"De Bosscher","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"9678","key":"10.1016\/j.cld.2024.06.018_bib51","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2024.06.018_bib54","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2024.06.018_bib55","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.018_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.06.018_bib58","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.cct.2020.106094","article-title":"Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis","volume":"96","author":"Dasarathy","year":"2020","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"10.1016\/j.cld.2024.06.018_bib59","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2024.01.031","article-title":"Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis","volume":"80","author":"Gawrieh","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.06.018_bib60","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.06.018_bib61","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"Patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.cld.2024.06.018_bib63","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/jama.2023.4902","article-title":"Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial","volume":"329","author":"Louvet","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jceh.2022.10.010","article-title":"Determining prognosis of ALD and alcohol-associated hepatitis","volume":"13","author":"Mehta","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.018_bib65","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.018_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14309\/ajg.0000000000001042","article-title":"Keratin-18: diagnostic, prognostic, and theragnostic for alcohol-associated hepatitis","volume":"116","author":"McClain","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2024.06.018_bib67","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.14309\/ajg.0000000000000912","article-title":"Severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers","volume":"115","author":"Atkinson","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib68","doi-asserted-by":"crossref","first-page":"100283","DOI":"10.1016\/j.jhepr.2021.100283","article-title":"Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis","volume":"3","author":"Sharma","year":"2021","journal-title":"JHEP Rep"},{"issue":"11","key":"10.1016\/j.cld.2024.06.018_bib69","first-page":"Cd001511","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","volume":"11","author":"Pavlov","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HC9.0000000000000393","article-title":"Steroid responsiveness in alcohol-associated hepatitis is linked to glucocorticoid metabolism, mitochondrial repair, and heat shock proteins","volume":"8","author":"Hardesty","year":"2024","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.cld.2024.06.018_bib71","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1210\/en.2018-00344","article-title":"The hepatic glucocorticoid receptor is crucial for cortisol homeostasis and sepsis survival in humans and male mice","volume":"159","author":"Jenniskens","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cld.2024.06.018_bib72","first-page":"e0393","article-title":"Steroid responsiveness in alcohol-associated hepatitis is linked to glucocorticoid metabolism, mitochondrial repair, and heatshock proteins","volume":"8","author":"Josiah Hardesty","year":"2024","journal-title":"Hepatology Communications"},{"issue":"12","key":"10.1016\/j.cld.2024.06.018_bib73","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.4049\/jimmunol.139.12.4122","article-title":"Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells","volume":"139","author":"Baumann","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.cld.2024.06.018_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A\u00a0randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.06.018_bib75","doi-asserted-by":"crossref","first-page":"785100","DOI":"10.3389\/falgy.2021.785100","article-title":"Human lung mast cells impair corticosteroid responsiveness in human airway smooth muscle cells","volume":"2","author":"Alzahrani","year":"2021","journal-title":"Front Allergy"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:34:14Z","timestamp":1778589254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1089326124000667"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.018","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}